These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15288840)

  • 61. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study.
    Rintala MA; Grénman SE; Järvenkylä ME; Syrjänen KJ; Syrjänen SM
    Clin Infect Dis; 2005 Dec; 41(12):1728-33. PubMed ID: 16288396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV Family Study.
    Rintala M; Grénman S; Puranen M; Syrjänen S
    J Clin Virol; 2006 Jan; 35(1):89-94. PubMed ID: 16112613
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.
    Perrons C; Jelley R; Kleter B; Quint W; Brink N
    J Clin Virol; 2005 Apr; 32(4):278-85. PubMed ID: 15780805
    [TBL] [Abstract][Full Text] [Related]  

  • 66. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
    Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
    Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence status and association with human papilloma virus of anal squamous proliferative lesions in a patient sample in Taiwan.
    Tsai TF; Kuo GT; Kuo LT; Hsiao CH
    Sex Transm Dis; 2008 Aug; 35(8):721-4. PubMed ID: 18650771
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus.
    Upadhyaya JD; Fitzpatrick SG; Islam MN; Bhattacharyya I; Cohen DM
    Head Neck Pathol; 2018 Dec; 12(4):500-510. PubMed ID: 29427033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Human papillomavirus (HPV) in laryngeal leukoplakia].
    Makowska W; Bogacka-Zatorska E; Rogoziński T
    Otolaryngol Pol; 2001; 55(4):395-8. PubMed ID: 11766316
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
    Gandolfo S; Castellani R; Pentenero M
    J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases.
    Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L
    Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proliferative verrucous leukoplakia: a case report.
    Lopes MA; Pazoki AE; Ord RA
    Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proliferative verrucous leukoplakia: a proposal for diagnostic criteria.
    Cerero-Lapiedra R; Baladé-Martínez D; Moreno-López LA; Esparza-Gómez G; Bagán JV
    Med Oral Patol Oral Cir Bucal; 2010 Nov; 15(6):e839-45. PubMed ID: 20173704
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Next-generation sequencing analysis for detecting human papillomavirus in oral verrucous carcinoma.
    Samman M; Wood H; Conway C; Berri S; Pentenero M; Gandolfo S; Cassenti A; Cassoni P; Al Ajlan A; Barrett AW; Chengot P; MacLennan K; High AS; Rabbitts P
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):117-125.e1. PubMed ID: 24908602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.
    Rintala M; Vahlberg T; Salo T; Rautava J
    Head Neck; 2019 May; 41(5):1499-1507. PubMed ID: 30536498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-risk human papillomavirus in patients with oral leukoplakia and oral squamous cell carcinoma-A multi-centre study in Sweden, Brazil and Romania.
    Sundberg J; Öhman J; Korytowska M; Wallström M; Kjeller G; Andersson M; Horal P; Lindh M; Giglio D; Kovács A; Sand L; Hirsch JM; Magda Araújo Ferracini L; de Souza ACMF; Parlatescu I; Dobre M; Hinescu ME; Braz-Silva PH; Tovaru S; Hasséus B
    Oral Dis; 2021 Mar; 27(2):183-192. PubMed ID: 32568421
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of human papillomavirus in verrucous carcinoma from HIV-seropositive patients.
    Cuesta KH; Palazzo JP; Mittal KR
    J Cutan Pathol; 1998 Mar; 25(3):165-70. PubMed ID: 9550316
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of human papilloma virus in oral leukoplakia.
    Bhargava A; Shakeel M; Srivastava AN; Raza TS; Rizvi S; Varshney P
    Indian J Cancer; 2016; 53(1):206-9. PubMed ID: 27146781
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Management of proliferative verrucous leukoplakia: Justification for a conservative approach.
    Borgna SC; Clarke PT; Schache AG; Lowe D; Ho MW; McCarthy CE; Adair S; Field EA; Field JK; Holt D; Risk JM; Rajlawat BP; Triantafyllou A; Shaw RJ
    Head Neck; 2017 Oct; 39(10):1997-2003. PubMed ID: 28640498
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Segmentation of Oral Leukoplakia (OL) and Proliferative Verrucous Leukoplakia (PVL) Using Artificial Intelligence Techniques.
    Alshawwa SZ; Saleh A; Hasan M; Shah MA
    Biomed Res Int; 2022; 2022():2363410. PubMed ID: 35909480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.